ALEXION PHARMACEUTICALS INC 4
4 · ALEXION PHARMACEUTICALS INC · Filed Mar 13, 2014
Insider Transaction Report
Form 4
MADRI JOSEPH A
Director
Transactions
- Exercise/Conversion
Common Stock, par value $.0001 per share
2014-03-11$8.18/sh+30,000$245,400→ 209,217 total - Exercise/Conversion
Common Stock, par value $.0001 per share
2014-03-11$10.84/sh+30,000$325,200→ 239,217 total - Sale
Common Stock, par value $.0001 per share
2014-03-11$178.35/sh−50,000$8,917,500→ 189,217 total - Sale
Common Stock, par value $.0001 per share
2014-03-11$179.88/sh−10,000$1,798,800→ 179,217 total - Exercise/Conversion
Option to Purchase Common Stock
2014-03-11$8.18/sh−30,000$245,400→ 0 totalExercise: $8.18From: 2006-09-07Exp: 2016-06-07→ Common Stock, par value $.0001 per share (30,000 underlying) - Exercise/Conversion
Option to Purchase Common Stock
2014-03-11$10.84/sh−30,000$325,200→ 0 totalExercise: $10.84From: 2007-08-03Exp: 2017-05-03→ Common Stock, par value $.0001 per share (30,000 underlying)
Footnotes (2)
- [F1]This transaction was executed in multiple trades through a broker-dealer at prices ranging from $178.00 - $178.99. The price reported in this column reflects the weighted average sales price. Upon request, the reporting person will provide to the SEC staff full information regarding the number of shares sold at each price.
- [F2]This transaction was executed in multiple trades through a broker-dealer at prices ranging from $179.00 - $179.99. The price reported in this column reflects the weighted average sales price. Upon request, the reporting person will provide to the SEC staff full information regarding the number of shares sold at each price.